Hormone Replacement Therapy Market Size- By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By End Use- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Hormone Replacement Therapy Market Introduction and Overview

According to SPER Market Research, 'Hormone Replacement Therapy Market Size- By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By End Use- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Hormone Replacement Therapy Market is predicted to reach USD 63.47 billion by 2033 with a CAGR of 5.32%.

Hormone replacement therapy (HRT) is the use of hormones to supplement the human body's natural hormone production if it is insufficient. Patients who are deficient in thyroid or human growth hormone, for example, may benefit from hormone replacement treatment. Furthermore, menopausal women were regularly prescribed HRT to alleviate symptoms such as hot flushes, night sweats, sleep problems, psychological and Genito-urinary concerns (urinary frequency and vaginal dryness), and to prevent osteoporosis.

Furthermore, for the hormone replacement therapy, throughout the projection period, COVID-19 had a significant impact on the hormone replacement therapy sector. Drug launches have been cancelled and clinical trials have been postponed as a result of the shift in healthcare infrastructure to manage COVID-19. Patients with COVID-19 who had raised hormone levels during their hospitalisation were found to have a higher risk of disease severity and inflammation in both men and women.

Scope of the Report:

Report Metric Details

Market size available for years 2019-2033

Base year considered 2022

Forecast period 2023-2033

Segments covered By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By End Use

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Hisamitsu Pharmaceutical Co., Inc., Noven Pharmaceuticals, Inc., Merck KGA, Mylan N.V., Novartis International AG, Novo Nordisk A/S, and Pfizer Inc.

Hormone Replacement Therapy Market Segmentation:

By Route of Administration: Based on the Route of Administration, Global Hormone Replacement Therapy Market is segmented as; Oral, Parenteral, Others.

By Indication: Based on the Indication, Global Hormone Replacement Therapy Market is segmented as; Menopause, Hypothyroidism, Male hypogonadism, Growth hormone deficiency, Others.

By Distribution Channel: Based on the Distribution Channel, Global Hormone Replacement Therapy Market is segmented as; Hospital Pharmacies, Online Pharmacy, Retail Pharmacy.

By End Use: Based on the End Use, Global Hormone Replacement Therapy Market is segmented as; Hospitals, Homecare, Speciality Clinics, Others.

Product Code: HLCA2370

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Hormone Replacement Therapy Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Hormone Replacement Therapy Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Hormone Replacement Therapy Market

7. Global Hormone Replacement Therapy Market, By Therapy Type (USD Million)

7.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Therapy Type, 2023-2033
7.2. Estrogen hormone replacement therapy Filtration
7.3. Human growth hormone replacement therapy Pipes
7.4. Progestogen hormone replacement therapy
7.5. Testosterone hormone replacement therapy
7.6. Thyroid hormone replacement therapy

8. Global Hormone Replacement Therapy Market, By Route of Administration (USD Million)

8.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Route of Administration, 2023-2033
8.2. Oral
8.3. Parenteral
8.4. Others

9. Global Hormone Replacement Therapy Market, By Indication (USD Million)

9.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Indication, 2023-2033
9.2. Growth hormone deficiency
9.3. Hypothyroidism
9.4. Male hypogonadism
9.5. Menopause
9.6. Others

10. Global Hormone Replacement Therapy Market, By Distribution Channel (USD Million)

10.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By Distribution Channel, 2023-2033
10.2. Hospital Pharmacies
10.3. Online Pharmacy
10.4. Retail Pharmacy

11. Global Hormone Replacement Therapy Market, By End Use (USD Million)

11.1. Global Hormone Replacement Therapy Market Value Share and Forecast, By End Use, 2023-2033
11.2. Homecare
11.3. Hospitals
11.4. Speciality Clinics
11.5. Others

12. Global Hormone Replacement Therapy Market Forecast, 2019-2033 (USD Million)

12.1. Global Hormone Replacement Therapy Market Size and Market Share

13. Global Hormone Replacement Therapy Market, By Therapy Type, 2019-2033 (USD Million)

13.1. Global Hormone Replacement Therapy Market Size and Market Share By Therapy Type (2019-2026)
13.2. Global Hormone Replacement Therapy Market Size and Market Share By Therapy Type (2027-2033)

14. Global Hormone Replacement Therapy Market, By Route of Administration, 2019-2033 (USD Million)

14.1. Global Hormone Replacement Therapy Market Size and Market Share By Route of Administration (2019-2026)
14.2. Global Hormone Replacement Therapy Market Size and Market Share By Route of Administration (2027-2033)

15. Global Hormone Replacement Therapy Market, By Indication, 2019-2033 (USD Million)

15.1. Global Hormone Replacement Therapy Market Size and Market Share By Indication, (2019-2026)
15.2. Global Hormone Replacement Therapy Market Size and Market Share By Indication, (2027-2033)

16. Global Hormone Replacement Therapy Market, By Distribution Channel, 2019-2033 (USD Million)

16.1. Global Hormone Replacement Therapy Market Size and Market Share By Distribution Channel, (2019-2026)
16.2. Global Hormone Replacement Therapy Market Size and Market Share By Distribution Channel, (2027-2033)

17. Global Hormone Replacement Therapy Market, By End Use, 2019-2033 (USD Million)

17.1. Global Hormone Replacement Therapy Market Size and Market Share By End Use (2019-2026)
17.2. Global Hormone Replacement Therapy Market Size and Market Share By End Use (2027-2033)

18. Global Hormone Replacement Therapy Market, By Region, 2019-2033 (USD Million)

18.1. Global Hormone Replacement Therapy Market Size and Market Share By Region (2019-2026)
18.2. Global Hormone Replacement Therapy Market Size and Market Share By Region (2027-2033)
18.3. Asia-Pacific
- 18.3.1. Australia
- 18.3.2. China
- 18.3.3. India
- 18.3.4. Japan
- 18.3.5. South Korea
- 18.3.6. Rest of Asia-Pacific
18.4. Europe
- 18.4.1. France
- 18.4.2. Germany
- 18.4.3. Italy
- 18.4.4. Spain
- 18.4.5. United Kingdom
- 18.4.6. Rest of Europe
18.5. Middle East and Africa
- 18.5.1. Kingdom of Saudi Arabia
- 18.5.2. United Arab Emirates
- 18.5.3. Rest of Middle East & Africa
18.6. North America
- 18.6.1. Canada
- 18.6.2. Mexico
- 18.6.3. United States
18.7. Latin America
- 18.7.1. Argentina
- 18.7.2. Brazil
- 18.7.3. Rest of Latin America

19. Company Profile

19.1. Abbott Laboratories
- 19.1.1. Company details
- 19.1.2. Financial outlook
- 19.1.3. Product summary
- 19.1.4. Recent developments
19.2. Bayer AG
- 19.2.1. Company details
- 19.2.2. Financial outlook
- 19.2.3. Product summary
- 19.2.4. Recent developments
19.3. Eli Lilly and Company
- 19.3.1. Company details
- 19.3.2. Financial outlook
- 19.3.3. Product summary
- 19.3.4. Recent developments
19.4. F. Hoffmann-La Roche Ltd.
- 19.4.1. Company details
- 19.4.2. Financial outlook
- 19.4.3. Product summary
- 19.4.4. Recent developments
19.5. Hisamitsu Pharmaceutical Co. Inc.
- 19.5.1. Company details
- 19.5.2. Financial outlook
- 19.5.3. Product summary
- 19.5.4. Recent developments
19.6. Merck KGA
- 19.6.1. Company details
- 19.6.2. Financial outlook
- 19.6.3. Product summary
- 19.6.4. Recent developments
19.7. Mylan N.V.
- 19.7.1. Company details
- 19.7.2. Financial outlook
- 19.7.3. Product summary
- 19.7.4. Recent developments
19.8. Novartis International AG
- 19.8.1. Company details
- 19.8.2. Financial outlook
- 19.8.3. Product summary
- 19.8.4. Recent developments
19.9. Noven Pharmaceuticals, Inc.
- 19.9.1. Company details
- 19.9.2. Financial outlook
- 19.9.3. Product summary
- 19.9.4. Recent developments
19.10. Novo Nordisk A/S
- 19.10.1. Company details
- 19.10.2. Financial outlook
- 19.10.3. Product summary
- 19.10.4. Recent developments
19.11. Pfizer Inc
- 19.11.1. Company details
- 19.11.2. Financial outlook
- 19.11.3. Product summary
19.12. Others